82 FR 219 pgs. 52941-52942 - Importer of Controlled Substances Application: Anderson Brecon, Inc.
Type: NOTICEVolume: 82Number: 219Pages: 52941 - 52942
Pages: 52941, 52942Docket number: [Docket No. DEA-392]
FR document: [FR Doc. 2017-24674 Filed 11-14-17; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Anderson Brecon, Inc.
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 15, 2017. Such persons may also file a written request for a hearing on the application on or before December 15, 2017.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
[top] The Attorney General has delegated his authority under the Controlled
In accordance with 21 CFR 1301.34(a), this is notice that on June 10, 2016, Anderson Brecon, Inc., DBA PCI of Illinois, 5775 Logistics Parkway, Rockford, Illinois 61109 applied to be registered as an importer of Ajulemic Acid (7370), a basic class of controlled substance listed in schedule I.
The company plans to import the listed controlled substances in over-encapsulated tablets for clinical trial only. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale.
Dated: November 7, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-24674 Filed 11-14-17; 8:45 am]
BILLING CODE 4410-09-P